Skip to main content

Advertisement

Table 1 Patient characteristics and clinical data

From: Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy

Characteristics   N = 70
Age at diagnosis Median 58 years
  Range 26-89
Gender Male 42 (60%)
  Female 28 (40%)
Race White 52 (74%)
  Black 15 (21%)
  Other or unknown 3 (4%)
Clinical disease stage (at diagnosis) II 25 (36%)
  III 39 (56%)
  IV 6 (9%)
Pathological disease response Complete response (pCR) 12 (17%)
  Major response (pMR) 13 (19%)
  Limited response (pLR) 45 (64%)
Treatment response Downstaged 30 (43%)
  No change 33(47%)
  Upstaged 7 (10%)
Recurrence No 45 (64%)
  Yes 25 (36%)
  Local recurrence 7 (10%)
  Distant recurrence 13 (19%)
  Both local and distant 5 (7%)
Status (censored April 23, 2008) Alive 41 (59%)
  Dead 29 (41%)
  1. pCR: Complete response; pMR: Major response; pLR: Limited response